Mainz Biomed N.V. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.28M0.49M0.58M0.53M0.90M0.89M
Cost of Revenue 0.34M0.37M0.40M0.35M0.39M0.32M
Gross Profit -0.06M0.12M0.18M0.18M0.51M0.57M
Operating items
Research & Development 0.25M0.31M0.48M5.02M9.59M5.84M
Selling, General & Administrative 0.43M0.37M8.46M15.21M11.41M6.57M
Restructuring Costs 0.28M
Other Operating Expenses -0.04M0.09M-1.97M0.06M0.35M-2.96M
Operating Expenses 0.86M0.80M9.90M26.63M27.15M19.27M
Operating Income -0.92M-0.67M-9.72M-26.44M-26.64M-18.70M
EBIT -0.92M-0.67M-9.72M-26.44M-26.64M-18.70M
Non-operating items
Other Non Operating Income 0.66M
Non Operating Income -0.25M-2.96M
Net income details
EBT -0.96M-0.59M-11.69M-26.39M-26.30M-21.65M
Profit After Tax -0.96M-0.59M-11.69M-26.39M-26.30M-21.65M
Investment Income -0.50M-0.10M
Income from Continuing Operations -0.96M-0.59M-11.69M-26.39M-26.30M-21.65M
Consolidated Net Income -0.96M-0.59M-11.69M-26.39M-26.30M-21.65M
Income towards Parent Company -0.96M-0.59M-11.69M-26.39M-26.34M-21.65M
Net Income towards Common Stockholders -0.96M-0.59M-11.69M-26.39M-26.34M-21.65M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.29M0.29M0.36M0.42M0.64M
Shares Outstanding (Diluted Average) 5.61M7.21M14.16M0.41M0.97M
EBITDA -0.92M-0.67M-9.72M-26.44M26.80M21.76M